<DOC>
	<DOCNO>NCT02628197</DOCNO>
	<brief_summary>The purpose interventional study investigate impact control systemic inflammation scale root planing ( SRP ) bone mineral density ( BMD ) osteopenic post-menopausal woman Chronic periodontitis ( CP ) . Out 68 osteopenic postmenopausal woman CP , 34 participant included test control group . BMD , hsCRP periodontal parameter record baseline 6 month .</brief_summary>
	<brief_title>Effect Periodontitis Bone Mineral Density Postmenopausal Women</brief_title>
	<detailed_description>Rapid estrogen level decline menopause associate systemic bone loss woman lead osteopenia/osteoporosis . Estrogen therapy ( ET ) improve bone mineral density ( BMD ) postmenopausal woman . Currently , ET associate statistically significant increase risk breast cancer , stroke , thromboembolic event . Easiest lifestyle modiﬁcation management low BMD probably adequate intake calcium vitamin D. Chronic inflammatory disease associate systemic bone loss . Bone target many inflammatory rheumatic disease like rheumatoid arthritis ( RA ) , ankylose spondylitis ( AS ) . Low bone mineral density also document patient Systemic lupus erythematosus ( SLE ) . Periodontitis chronic condition support tissue teeth . It report 30 % individual age 50 year suffer severe periodontitis.Hujoel et al conclude mean periodontal surface area patient periodontitis large 8-20cm2 . The inflamed ulcerated subgingival pocket epithelium may allow many gram negative obligate anaerobic bacteria enter bloodstream . Bacterial component endotoxins major outer membrane protein may also disseminate . Studies systemic influence periodontitis theorize locally produce pro-inflammatory cytokine interleukin-1 ( IL-1 ) , tumour necrosis factor-alpha ( TNF-α ) , interleukin-6 ( IL-6 ) prostaglandin-E2 ( PGE2 ) may release circulation exercise distant effect . These inflammatory cytokine report implicated distinctive loss bone density osteoporosis effect osteoclast activity . C-reactive protein ( CRP ) extremely sensitive non-specific acute phase reactant produce response tissue damage , inflammation , infection hypoxia . It serological marker systemic inﬂammation . Previous study elderly female large population base sample report high serum level CRP associate low BMD . A study also implicate CRP ≥ 4.2mg/l may use identify group rapid bone loss old people . Various study conclude high level CRP patient periodontitis control . D Auito report CRP reduction 0.5mg/l 6 month non- surgical periodontal therapy patient chronic periodontitis ( CP ) .Epidemiological study Buffalo , New York , report elevated CRP blood plasma among patient severe periodontal attachment loss comparison individual minimal attachment loss . Various cross sectional study report association osteoporosis periodontal disease post-menopausal woman . A recent study demonstrate severe clinical attachment loss ( CAL ) independently associate low BMD femoral neck postmenopausal woman . These study infer osteoporosis risk factor periodontitis . It difficult infer cause effect relationship cross sectional study . The basis association osteoporosis periodontitis may either osteoporosis influence periodontitis and/or vice-versa and/or share common risk factor . Inflammation report contribute towards post-menopausal deterioration BMD . Levels inflammatory cytokine responsible loss bone density e.g . IL-1β , IL-6 , TNF-α osteoporosis report increased systemic circulation CP . Hence , hypothesize CP , inflammatory disorder large wind surface area , may add systemic inflammatory burden may consequently contribute towards deterioration BMD post-menopausal woman . So , control systemic inflammatory burden scale root planing ( SRP ) may adjunctive effect management osteopenia/osteoporosis patient . Taking consideration observation , present study undertaken evaluate impact control inflammation SRP BMD osteopenic post-menopausal woman periodontitis . MATERIALS AND METHODS Study Population Patients interventional study recruit out-patient department department Periodontics Oral Implantology department Oral Medicine , Post Graduate Institute Dental Sciences , Rohtak . The study protocol carry accordance ethical standard outline 1975 Declaration Helsinki , revise 2013 . The protocol approve Institutional Review Board , Pt . B. D. Sharma University Health Sciences , Rohtak ethical approval obtain ethical committee PGIDS , Rohtak . ( PGIDS/IEC/2014/114 ) . Prior write informed consent take patient explain procedure along risk benefit language . The patient accept study meet follow inclusion criterion : 1 ) osteopenic post-menopausal woman CP 20 natural teeth ( exclude third molar ) ; 2 ) age 52 -59 year ; 3 ) history natural menopause since 5 year . Osteopenia criterion per World Health Organization ( WHO ) criterion : standardize T-score -1.0 -2.5 . CP criterion consider study : least 4 teeth one sit probe depth ≥ 4mm , CAL ≥ 3mm presence bleed probe site . Exclusion criterion include follow : 1 ) systemic disease know affect BMD hsCRP level include RA , AS , SLE , IBD , COPD ; 2 ) systemic disease know affect course periodontal disease like diabetes mellitus immunological disorder ; 3 ) treatment follow drug previous 3 month : steroid , immune suppressant , antibiotic , anti-inflammatory , statin , lipid lower drug , anti-convulsants , thiazide diuretic agent , anti-coagulants host modulatory drug ; 4 ) recent history presence acute chronic infection ; 5 ) history metabolic bone disease , thyroid parathyroid disease gastro-intestinal disorder ; 6 ) early onset menopause ; treatment systemic medication osteoporosis/osteopenia include calcium vitamin D supplementation , bisphosphonates etc . ; 7 ) history hysterectomy hormone replacement therapy ; 8 ) current former smoker use smokeless tobacco form ; 9 ) periodontal treatment within past one year prior inclusion study STUDY GROUPS The test group consist 34 participant receive SRP along calcium ( 500mg ) vitamin D ( 250I.U . ) supplementation ( Shelcal , torrents pharmaceutical limited , Gujarat , India ) twice day 6 month control group consist 34 participant receive calcium ( 500mg ) vitamin D ( 250I.U . ) supplementation* twice day 6 month . Participants without chief complaint reference periodontitis express inability undergo periodontal treatment immediately near future include control group . BMD measurement BMD participant evaluate use Dual Energy X-ray Absorptimetry ( DXA , Hologic QDR explorer version 12.6:3 ; Hologic Inc. , Bedford , MA , USA ) lumbar spine region ( L1-L4 ) exposure .07mGy 90 second baseline 6 month follow-up . The improvement BMD ( T-score ) 6 month baseline take primary outcome . Sample collection All blood sample collect baseline 6 month follow-up serum high-sensitivity C - reactive protein ( hsCRP ) . Venous blood anticubital vein collect apply tourniquet plain vacutainer tube without additive . It measure use serum sample . hsCRP estimation Serum hsCRP level assess use kit high-sensitivity methodology‡ ( C - reactive protein ( Latex ) High-Sensitive Assay , Roche Diagnostics , GmbH , Mannheim , USA ) autoanalyser accord manufacturer 's instruction . The test principle particle enhance immune-turbidimetric assay , human CRP agglutinate latex particle coat monoclonal anti-CRP antibody . The turbidity induce formation immune complex measure 546 nm . Periodontal examination After selection study , participant underwent full-mouth periodontal examination baseline 6 month standardize way use illumination standard dental light , mouth mirror , tweezer , manual calibrate probe ( PCP-UNC 15 Hu-Friedy , Chicago , IL , USA ) explorer . Following parameter take consideration : Plaque index ( PI ) ( Silness &amp; Loe ) ; Gingival index ( GI ) ( Loe &amp; Silness ) ; Bleeding probing ( BOP ) ; Pocket depth ( PD ) ; Attachment loss ( AL ) . To preclude inter examiner variability , periodontal examination perform one train calibrated examiner ( AB ) . The calibration protocol include determination examiner reproducibility , record twice visit 10 % representative sample . Operator calibration GI base intra examiner exact reproducibility 85 % site . For PD AL , calibration base intra-examiner reproducibility within 1 mm &gt; 90 % &gt; 85 % site . Periodontal treatment Patients TG receive full mouth scale root planing ( SRP ) use manual instrument ultrasonic scaler ( Suprasson P5 Booster ; Satelec , Merignac Cedex , France ) 2-4 session . The patient provide information periodontal disease , oral hygiene instruction give appointment . The patient instruct use mechanical technique toothbrush interdental-floss study period . Mouthwashes /or antimicrobial prescribe . Patients ask bring remain tablet leave assess compliance . Patient compliance consider ≥90 % tablet consume . Weekly reminder also give patient personal phone call . Statistical analysis Post-hoc analysis do use statistical software ( G*Power v.3.0.10 , Heinrich-Heine University Düsseldorf , Düsseldorf , Germany ) . Effect size determine follow rule standardize difference give output variable ( BMD ) sample size 62 significance level two side α= 0.05 . This come 1 . With measurement , statistical power exceed 90 % allocation ratio 1:1 . The normality data distribution examine use Shapiro-wilk test . PD hsCRP find normally distribute , whereas rest parameter non-normally distribute . The descriptives express mean±SD . The significance difference group age , BMD , PI , GI , BOP AL baseline compare Mann-whitney U test . Independent T test use hsCRP PD purpose . Wilcoxon sign rank test Paired T test use evaluate difference baseline 6 month follow group . The difference group assess use Mann whitney U test Independent T test whichever applicable . A binomial logistic regression model fit relate Normal T-score patient outcome variable treatment group categorical predictor variable . The Hosmer-Lemeshow goodness fit test apply verify whether present test fit well . Model adjust covariate statistical analysis 2 tail , significance level 0.05 ( SPSS v.21 , IBM , Chicago , IL ) .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>1. osteopenic postmenopausal woman CP 20 natural teeth ( exclude third molar ) 2. age 52 59 year 3. history natural menopause since 5 year . Osteopenia criterion per World Health Organization ( WHO ) criterion : standardize Tscore 1.0 2.5 . CP criterion consider study : least 4 teeth one sit probe depth ≥ 4mm , CAL ≥ 3mm presence bleed probe site . 1. systemic disease know affect BMD hsCRP level include RA , AS , SLE , IBD , COPD 2. systemic disease know affect course periodontal disease like diabetes mellitus immunological disorder 3. treatment follow drug previous 3 month : steroid , immune suppressant , antibiotic , antiinflammatories , statin , lipid lower drug , anticonvulsant , thiazide diuretic agent , anticoagulant host modulatory drug 4. recent history presence acute chronic infection 5. history metabolic bone disease , thyroid parathyroid disease gastrointestinal disorder 6. early onset menopause ; treatment systemic medication osteoporosis/osteopenia include calcium vitamin D supplementation , bisphosphonates etc . 7. history hysterectomy hormone replacement therapy 8. current former smoker use smokeless tobacco form 9. periodontal treatment within past one year prior inclusion study</criteria>
	<gender>Female</gender>
	<minimum_age>52 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>